We’re happy to have this incredible group of interns join #theHerd this summer! Interns are partnering with other Herd members on projects that will be presented at our annual internship symposium in August. #NationalInternDay #CRISPR #CARtcells #humanresource
About us
Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. We believe the future of cell therapy is off-the-shelf, and we are advancing our pipeline of off-the-shelf, or allogeneic, cell therapies from our CAR-T cell therapy platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases.
- Website
-
http://cariboubio.com
External link for Caribou Biosciences
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Berkeley, CA
- Type
- Public Company
- Founded
- 2012
- Specialties
- Next-generation CRISPR genome editing, allogeneic CAR-T cell therapies, oncology, and autoimmune
Locations
-
Primary
Get directions
2929 7th St, Suite 105
Berkeley, CA 94710, US
Employees at Caribou Biosciences
Updates
-
Caribou Biosciences reposted this
I’m hoping my network can help support my colleagues. This week was difficult as several members of Caribou’s preclinical research team were laid off. These individuals include some of the most talented, innovative, and passionate professionals in the industry. If your company is hiring experts in #immunology, #genomeediting, #CRISPRtechnology, #iPSC derived #celltherapies, #NKcells, #tcelltherapeutics, #proteinengineering, #productdevelopment, please let me know and I would be more than happy to connect you with these qualified and dedicated professionals.
-
Members of Caribou’s clinical team will be at the Pan Pacific Lymphoma Conference this week. Check out our poster online sharing our recently reported update on the CB-010 ANTLER Phase 1 trial. Learn more: https://bit.ly/3KUBZHB #PPLC24 #lymSM #oncology
-
-
Congratulations to Caribou’s chief legal officer, Barbara McClung, JD, for being selected as a 2024 member of the WIB Boardroom Ready program! This executive development program is designed to fuel women’s participation on corporate boards and we couldn’t be prouder to have a Caribou representative amongst the esteemed program alumni.
We are proud to present our 2024 Boardroom Ready Cohort! The Boardroom Ready Program was created in 2016 to assist executive women in the life sciences secure their first director role, and to date the program has 200 alumnae who make a lasting and positive impact on corporate boards. Join us in congratulating the 25 women that make up this outstanding 2024 Boardroom Ready Cohort 👏 Learn more about the program and this cohort on our website: https://lnkd.in/gVc6sFtM Allison Gaw | Barbara McClung | Barbara Wood | Beth Clarke | Bethany Dudek | Charlotte Arnold | Christine Loh | Eleni Lagos | Heather Arnett | Hong I. Wan | Janneke Meulenberg | Jen Beachell | Jennifer Leonard | Jessica Baker Flechtner | Katarina Luptakova | Kitty Yale | Laura Richman, MBA, PhD, DVM, DACVP | Lauren D'Angelo, MBA | Lauren White | Leslie Meltzer | Pallavi Garg | Rachel B. Wagman, M.D. | Shelby Walker | Sonali Fonseca, PhD | Valerie D'Souza Jaiswal
-
-
Today we announced the appointment of Terri Laufer, MD, to our scientific advisory board! Dr. Laufer is an expert immunologist who will bring invaluable insights to our team as we advance our GALLOP clinical trial for #lupus and the partial HLA matching strategy for CB-010. Welcome to #theHerd, Dr. Laufer! https://bit.ly/3S1cg42
-
In celebration of Pride Month, the Queeribou employee resource group hosted this month’s happy hour. The Queeribou ERG aims to provide the Herd a safe and inclusive space to build community, opportunities for personal and professional development, and pathways for involvement in company and community efforts to advance #LGBTQIA+ equality. They also host a spectacular party. Happy Pride! #CaribouWay
-
-
What advancements have been made to made to reduce off-targeting editing? Caribou’s CSO Steven Kanner, PhD, provides insights on this panel discussion with Cell & Gene host Erin Harris: https://lnkd.in/ga3ZgTup
-
-
Today, Caribou is observing #Juneteenth – a national holiday that commemorates the emancipation of enslaved African Americans in the United States. This day of remembrance stands as a reminder of the work that still needs to be done to achieve #equality for all. #FreedomDay #EmancipationDay
-
-
Tomorrow, Caribou Biosciences chief financial officer, Jason O'Byrne, will join the San Francisco CFO Leadership Council panel discussion on considerations and perspectives for SMID cap biotech companies in 2024 and beyond. Register for the the event here: https://lnkd.in/euVeUu72
-